Literature DB >> 12380797

Rat periodontal fibroblast responses to bacterial lipopolysaccharide in vitro.

Heni Susilowati1, A L Supartinah Santoso, Izzata Barid, Wihaskoro Sosroseno.   

Abstract

Rat periodontal ligament fibroblasts and gingival fibroblasts were stimulated with lipopolysaccharide from Escherichia coli. Cell proliferation and both interleukin-1beta and nitric oxide production were determined by a colorimetric, enzyme-linked immunosorbent assay and the Griess reaction, respectively. The results showed that at lipopolysaccharide concentration up to 100 ng per well, the cell proliferation of periodontal ligament fibroblasts was higher than that of gingival fibroblasts. No significant difference between the levels of interleukin-1beta produced by periodontal ligament and gingival fibroblasts can be observed. At high concentration of lipopolysaccharide (1000 ng/well), the levels of nitric oxide in the periodontal ligament fibroblasts cultures were higher than those in the gingival fibroblasts cultures. These results suggest those rat periodontal ligament and gingival fibroblasts may respond differently to lipopolysaccharide and, thus, may be different periodontal fibroblast subpopulations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12380797

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  2 in total

1.  Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway.

Authors:  Zhengyu He; Yuan Gao; Yuxiao Deng; Wen Li; Yongming Chen; Shunpeng Xing; Xianyuan Zhao; Jia Ding; Xiangrui Wang
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

2.  Epigenetic regulation of Thy-1 gene expression by histone modification is involved in lipopolysaccharide-induced lung fibroblast proliferation.

Authors:  Zhengyu He; Xiangrui Wang; Yuxiao Deng; Wen Li; Yongming Chen; Shunpeng Xing; Xianyuan Zhao; Jia Ding; Yuan Gao
Journal:  J Cell Mol Med       Date:  2013-01-11       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.